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Transportin SR2 (TRN-SR2) is a -type karyopherin responsible for the nuclear
import of specific cargoes, including serine/arginine-rich splicing factors. The
protein has been implicated in a variety of human diseases, including HIV
infection, primary biliary cirrhosis and limb-girdle muscular dystrophy 1F.
Towards understanding its molecular mechanism, a 2.9 A˚ resolution crystal
structure of human TRN-SR2 complexed with the small GTPase Ran has been
determined. TRN-SR2 is composed of 20 -helical HEAT repeats forming a
solenoid-like fold. The first nine repeats form a ‘cradle’ for the binding of
RanGTP, revealing similarities but also differences with respect to the related
importin 13 complex.
1. Introduction
Compartmentalization in the eukaryotic cell allows tight regulation
of biological functions such as transcription and translation, but it
also necessitates active transport of complex macromolecules in and
out of the nucleus via the nuclear pore complex (NPC; Hoelz et al.,
2011). Such transport relies on soluble factors (importins and
exportins) belonging to the karyopherin- family (Stewart, 2007;
Chook & Su¨el, 2011). The karyopherins shuttle their cargoes between
the cytoplasm and the nucleus via a GTP-dependent process which
relies on a small GTPase called Ran (Ras-related nuclear protein).
Specifically, nuclear import is driven by the gradient of the GTP-
bound form of Ran, which is enriched in the nucleus. After binding
the cargo in the cytoplasm, the importin docks to the cytoplasmatic
side of the NPC and is then transferred to the other side, driven by
transient interactions with nucleoporins (D’Angelo & Hetzer, 2008).
Once in the nucleus, the importin–cargo complex dissociates owing to
the competitive binding of RanGTP to the importin, followed by the
return of the importin–RanGTP complex to the cytoplasm and GTP
hydrolysis (Lee et al., 2005).
Here, we focus on human transportin SR2 (TRN-SR2), a -type
importin (Lai et al., 2000). Both TRN-SR2 and its splice variant TRN-
SR1 are encoded by the tnpo3 gene (Yun et al., 2003). A characteristic
feature of TRN-SR2 is its ability to import serine/arginine-rich
proteins (SR proteins), in particular splicing factors. Like other
family members, TRN-SR2 is predicted to consist of 20 consecutive
-hairpin motifs (two antiparallel -helices joined by a short linker)
known as HEAT repeats (Andrade & Bork, 1995). The stacked
HEAT repeats are generally believed to create a structure with
considerable plasticity, which provides adaptive binding of different
cargoes and regulatory proteins (Cook et al., 2007). While forming
a single continuous physical domain, the HEAT-based karyopherins
include distinct and sometimes overlapping functional regions.
In particular, their N-terminal part binds RanGTP, whereas the
C-terminal part is generally responsible for cargo binding (Lai et al.,
2000).
Importantly, TRN-SR2 has been implicated in a variety of human
diseases, including human immunodeficiency virus (HIV) infection
(Brass et al., 2008; Christ et al., 2008; Ko¨nig et al., 2008), primary
biliary cirrhosis (PBC; Hirschfield et al., 2010) and limb-girdle
muscular dystrophy 1F (LGMD1F; Melia` et al., 2013; Torella et al.,
2013). The role of TRN-SR2 in the HIV life cycle has been well
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studied. Yeast two-hybrid screening initially identified TRN-SR2 as a
direct binding partner of HIV integrase (Christ et al., 2008), a finding
that was later confirmed by other approaches (Krishnan et al., 2010;
Larue et al., 2012). Using fluorescent techniques, it has been
demonstrated that TRN-SR2 is directly involved in the nuclear
import of the HIV pre-integration complex, leading to the estab-
lishment of infection (Christ et al., 2008). Next, hereditary limb-girdle
muscular dystrophy 1F was linked to a single nucleotide deletion in
the stop codon of the tnpo3 gene. This mutation was shown to result
in an extended protein of either 938 (form A) or 1018 (form B) amino
acids, compared with the native TRN-SR2 of 923 residues. The
mutated protein accumulates in the outer rim of the nuclear
membrane, suggesting disturbed nuclear transport (Melia` et al., 2013;
Torella et al., 2013). Given both the fundamental aspect of the TRN-
SR2-dependent nuclear import and the above-mentioned disease
context, it is not surprising that this protein has recently gained
interest and has been actively studied at the biochemical and cellular
levels (Christ et al., 2008; De Houwer et al., 2012; Larue et al., 2012;
Taltynov et al., 2013). As the next major step, here we present the
atomic structure of human TRN-SR2, which was made possible by
resolving its complex with Ran at 2.9 A˚ resolution using X-ray
crystallography.
2. Materials and methods
Both full-length human TRN-SR2 and full-length human RAN
mutant Q69L (which is practically incapable of GTP hydrolysis) were
overexpressed in Escherichia coli BL21 (DE3) Rosetta pLysS cells
using the pETHSUMO vector (Weeks et al., 2007). The expressed
products were fusions containing an N-terminal 6His tag, the small
ubiquitin-like modifier (SUMO) protein, a SUMO hydrolase clea-
vage site and the protein sequence of interest. After digesting the
vector withHindIII and KpnI, the sequences encoding Homo sapiens
TRN-SR2 (residues 3–923) and RanQ69L (residues 1–216) were
inserted using the In-Fusion system (Clontech).
Bacterial cultures were grown at 24C until an OD600 nm of 4.0 was
reached, and then for a further 24 h at 18C. The cells expressing
TRN-SR2 and RanQ69L were pelleted by centrifugation and resus-
pended in buffer A (20 mM Tris pH 7.5, 200 mM NaCl, 15 mM
imidazole, 5 mM -mercaptoethanol) and buffer B (50 mM Tris pH
7.5, 150 mM NaCl, 4 mM MgCl2, 15 mM imidazole, 10% glycerol,
2.5 mM -mercaptoethanol), respectively. After the addition of 5 ml
Benzonase per 100 ml, the cells were sonicated on ice for 2 min with
20% amplitude and 30/10 s on/off pulses using a Branson Digital
Sonifier. The procedure was repeated twice with 15 min in between.
The lysates were cleared at 18 000g for 30 min at 4C and were then
applied onto an Ni2+–NTA (GE Healthcare) column using buffers A
and B for TRN-SR2 and RanQ69L, respectively, followed by elution
with the corresponding buffer supplemented with 500 mM imidazole.
The tags were then cleaved off by overnight incubation with SUMO
hydrolase at a 1:500 molar ratio at 4C in buffers A and B, respec-
tively. This was followed by a second pass through the Ni2+–NTA
column, whereby the flowthrough containing the cleaved protein
was collected while the uncleaved protein and the protease, both
containing the His tag, were retained on the column. For TRN-SR2,
the buffer was subsequently exchanged to 20 mM Tris pH 7.5, 50 mM
NaCl, 5 mM DTT using an Ultra-15 ultrafiltration device (Amicon),
which was followed by ion-exchange chromatography on a 5 ml
HiTrap Q HP column (GE Healthcare) using a linear gradient of
50 mM to 1M NaCl. To load Ran with GTP, the protein was incu-
bated for 30 min at room temperature with a fivefold molar excess of
GTP and 20 mM EDTA. The loading was stopped by the addition
of 40 mM MgCl2 followed by dialysis against 50 mM Tris, 150 mM
NaCl, 5 mM DTT pH 7.5. For complex formation, TRN-SR2 and
RanQ69LGTP were mixed in a 1:2 molar ratio and incubated on ice for
2 h, followed by size-exclusion chromatography on a HiLoad 16/60
Superdex 200 prep-grade column (GE Healthcare) in 20 mM Tris pH
7.5, 50 mM NaCl, 5 mM DTT. Prior to crystallization, the complex
was concentrated to 9.8 mg ml1.
Initial screening for crystallization of the TRN-SR2–RanQ69LGTP
complex was performed using commercial screens and a Mosquito
crystallization robot (TTP Labtech). Small needles could be obtained
in 400 nl sitting drops using The Protein Complex Suite (Qiagen)
condition 45 [100 mM MES pH 6.5, 5%(v/v) MPD, 15%(w/v) PEG
6000] at 20C. Subsequently, larger crystals could be obtained in 3 ml
hanging drops equilibrated against an equivalent reservoir solution
but with a slightly higher pH (6.7). After several rounds of micro-
seeding, the best crystal reached dimensions of 150  30  20 mm in
10 d. X-ray diffraction data were collected on the PROXIMA 2A
beamline (Synchrotron Soleil, Saint-Aubin, France) using a micro-
focus 10  5 mm beam with 0.979 A˚ wavelength. The crystals were
briefly soaked in mother liquor supplemented with 30% MPD and
flash-cooled in liquid nitrogen. To limit radiation damage to the thin
crystal, five different spots on the crystal were exposed; each was used
to collect a 20 rotation wedge. Data were processed with XDS
(Kabsch, 2010) and scaled with AIMLESS (Evans, 2006). The crystals
contained one protein complex per asymmetric unit (Table 1).
Initially, we failed to phase the data by molecular replacement
using as a search model our homology-modelled structure of the
TRN-SR2–RanQ69LGTP complex (Taltynov et al., 2013), as well as
any available experimental structures of related importins or their
complexes with Ran, including the complex of a closely related
human importin 13 (Imp13) with yeast RanGTP (PDB entry 2x19;
Bono et al., 2010). In retrospect, this difficulty could be explained by
significant differences in the overall conformation. However, it was
possible to obtain the correct molecular-replacement solution, albeit
with a marginal contrast, by searching with only the RanGTP from
the latter structure using MOLREP (Vagin & Teplyakov, 2010). This
can be rationalized by the remarkably high conservation between
human and yeast Ran (90% sequence identity), even though this
structural communications
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Table 1
Crystallographic data-collection and refinement statistics.
Overall Inner shell Outer shell
Data collection
Space group P212121
Unit-cell parameters (A˚) a = 74.2, b = 110.0, c = 148.5
Resolution range (A˚) 44–2.9 44–13 3.0–2.9
No. of unique reflections 27515 348 2035
Multiplicity 4.1 3.5 4.1
Completeness (%) 99.6 95.3 99.9
hI/(I)i 6.9 15.5 1.6
CC1/2†‡ 0.990 0.986 0.516
Rmerge‡ 0.146 0.052 1.00
Rmeas‡ 0.168 0.061 1.15
Wilson B factor (A˚2) 60.7
Refinement
Rwork 0.222
Rfree§ 0.276
No. of non-H atoms 8625
R.m.s.d., bonds (A˚) 0.003
R.m.s.d., angles () 0.79
Ramachandran favoured/outliers (%) 94.3/0.2
MolProbity score 1.8
Average B factor (A˚2) 73.5
† Half-set correlation of intensities. ‡ As output by AIMLESS (Evans, 2006). § As
calculated using a ‘free’ set of 1381 reflections (5%).
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protein makes up only 15% of the total complex mass. With the
Ran molecule in place, a further MOLREP search could position a
segment of the Imp13 structure from the complex containing HEAT
repeats 1–5. With these two elements in place, anotherMOLREP run
could correctly position a segment containing repeats 6–9. Such an
assembled partial structure yielded a crystallographic free R factor
of 0.54, which could be improved to 0.51 by automated refinement
in REFMAC (Murshudov et al., 2011), but only if the ‘jelly-body’
restraints were enabled. At this point, HEATrepeats 10–13 of Imp13
could be approximately placed into the electron-density map,
followed by further refinement and placement of additional repeats
until the model was complete. After multiple cycles of manual
rebuilding using Coot (Emsley et al., 2010) and refinement using
PHENIX (Adams et al., 2010), a final model with good quality was
obtained (Table 1). Atomic coordinates and structure factors have
been deposited in the Protein Data Bank (http://www.pdb.org) under
accession code 4ol0. Figures were prepared with PyMOL (http://
www.pymol.org/). The protein complexes were analyzed with the
PISA algorithm (Krissinel & Henrick, 2007) using an online server
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html).
3. Results and discussion
Previously, we have studied the detailed biochemical properties of
human TRN-SR2, and in particular characterized its complex with
the catalytically inactive Q69L mutant of human Ran (Taltynov et al.,
2013). For the current work, we have changed the overexpression
system for both proteins, which yielded highly pure tag-free samples.
As a result, after forming the TRN-SR2–RanQ69LGTP complex,
single crystals could be grown. Despite their small size, the use of
a microfocus synchrotron beam and an optimized data-collection
strategy allowed us to measure a complete 2.9 A˚ diffraction data set
(Table 1). Phasing of the data only became possible via a carefully
chosen molecular-replacement protocol, whereby the RanGTP
molecule and a number of the N-terminal HEAT repeats of TRN-
SR2 could be positioned. This was followed by gradual building of
the remaining structure. Of note, we were also able to obtain large
(>100 mm in each direction) crystals of human TRN-SR2 alone, but
despite extensive optimization efforts these crystals diffracted X-rays
to only about 6 A˚ resolution (O. Taltynov, V. G. Tsirkone and S. V.
Strelkov, unpublished results).
The asymmetric unit of the TRN-SR2–RanQ69LGTP crystals
contains a single copy of the complex. The entire TRN-SR2 molecule
is well defined in the electron-density map, with the exception of
three linkers located between HEAT repeats 5 and 6 (residues 216–
220), the two helices of HEAT 14 (residues 598–605) and the two
helices of HEAT 20 (residues 884–888). The C-terminal section
(residues 180–216) of RanQ69L is also not visible, which is in line with
earlier predictions that this part is disordered (Vetter et al., 1999;
Nilsson et al., 2002). Previously, C-terminally truncated Ran had been
used for the crystallization of the Imp13–Ran complex (Bono et al.,
2010).
Our crystal structure confirms that TRN-SR2 is a solenoid-type
protein consisting of 20 HEAT repeats, corroborating this hallmark
feature of the karyopherin- family (Andrade & Bork, 1995). Each
of the repeats is principally composed of two antiparallel -helices
connected through a loop, resulting in an ‘-hairpin’. The first -helix
of each repeat (called helix A) is always located on the outside of the
solenoid, while the second -helix (B) is on the inside (Fig. 1). The
axes of helices A and B, although principally antiparallel, usually
form a small crossing angle (about 15, left-handed). Exceptionally,
the C-terminal HEAT repeat 20 capping the open edge consists of
three helices.
Neighbouring -hairpins corresponding to HEAT repeats 2–9 are
roughly parallel to each other (while the very first repeat is signifi-
cantly rotated). Consequently, the overall conformation of the
N-terminal part of TRN-SR2 corresponds to a sector of a straight
solenoid (Fig. 1a). The same is valid for the C-terminal part (HEAT
repeats 10–20). However, there is a pronounced rotation of HEAT 10
with respect to HEAT 9, which are connected by a particularly short
linker. As a result, the overall shape of TRN-SR2 is that of a right-
handed screw rather than of a straight solenoid (Fig. 1b).
The core of the Ran molecule is an SH3 domain fold consisting of
six -strands. This core is supplemented by three -helices and two
surface loops referred to as Switch I (residues 37–45) and Switch II
structural communications
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Figure 1
(a, b) Overall view of the TRN-SR2–RanQ69LGTP complex in two perpendicular orientations. Each HEAT of TRN-SR2 is shown in a different colour, with -helices as
cylinders. Ran is represented by a sand-coloured surface. Both helices A and B of HEAT 1 are labelled. The three helices A, B and C of HEAT 20 are also indicated. For all
other repeats, only the outer helix A is labelled for clarity.
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(residues 69–85) (Fig. 2). Both loops are known to undergo extensive
conformational changes upon GTP binding (Stewart et al., 1998).
The binding of Ran to TRN-SR2 requires GTP and results in a
stable complex with an apparent Kd of 4.7  1.2 nM, as we have
shown in vitro using the AlphaScreen protein–protein interaction
assay (Taltynov et al., 2013). Indeed, our crystal structure reveals that
formation of the complex buries a very considerable part (22.9%,
2081 A˚2) of the total surface area of RanGTP. The complex is
stabilized in a synergistic manner by both hydrophobic interactions
and polar contacts (Fig. 3). The latter interactions are represented by
specific hydrogen bonds (to side groups or the main chain) and salt
bridges across the interface (Figs. 2 and 4). The N-terminal part of
TRN-SR2 clearly presents the specific site of RanGTP binding.
Indeed, HEATrepeats 1–9 make a ‘cradle’ roughly matching the size
of the globular Ran protein, albeit slightly larger. Correspondingly,
the binding of Ran mostly involves the B (inner) helices of HEAT
repeats 1–4 and 7–9, with some additional contacts made by repeats 5
and 6 (Figs. 2 and 3). On the Ran side, the exposed Switch II loop is
involved in important interactions with HEAT 1 and HEAT 2, while
Switch I makes further contacts with both HEAT 1 and HEAT 18
(Fig. 2). In addition, the N-terminal tips of helices B from repeats 15,
17 and 18 also make some contacts with the bound Ran (Fig. 3). It
is likely that these latter interactions are not essential for RanGTP
binding but rather occur simply because of the curved shape of the
TRN-SR2 molecule. At the same time, the expected site of cargo
binding is located in the C-terminal part of TRN-SR2 (Lai et al.,
structural communications
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Figure 2
Molecular detail of the interaction between TRN-SR2 and RanGTP. (a) Contacts of the main Ran-binding domain (HEAT repeats 1–9, intense blue). TRN-SR2 residues
forming salt bridges and hydrogen bonds to Ran are shown in green with side chains as sticks. The Ran molecule is shown as a yellow ribbon, with the Switch I and Switch II
regions highlighted in orange. The bound GTP is shown in red. (b) A close-up view of some interacting residues of TRN (green) and Ran (yellow) and the corresponding
weighted 2|Fo|  |Fc| electron-density map at the 1 level, presented in stereo. The salt bridges Glu152/Glu153(TRN)–Arg110(Ran) and Asp247(TRN)–Lys141(Ran) are
shown with dashed lines.
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2000). Since cargo release inside the nucleus is coupled to RanGTP
binding, there must also be an interplay between the two processes at
the structural level. Such interplay is facilitated by the solenoid shape
of the TRN-SR2 molecule, since the two binding sites are located
in proximity and may be sterically overlapping. Furthermore, the
HEAT-based structure is clearly prone to conformational plasticity,
as observed before for various crystallographic complexes of other
importins (Lee et al., 2006; Forwood et al., 2010). This plasticity is
likely to play an important role, whereby a particular binding partner
could come in contact with just the N-terminal part or the C-terminal
part, or with both of them as in the crystal structure presented here.
Finally, we have compared the structure of the TRN-SR2–
RanQ69LGTP complex with the corresponding complex of Imp13, a
-karyopherin with 22.6% amino-acid identity and 38% similarity to
structural communications
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Figure 3
Structure-based sequence alignment of TRN-SR2 and Imp13 based on their respective complexes with RanGTP. The conserved residues (identical or similar type) are shown
in blue. Magenta highlighting marks the residues that come into contact with RanGTP in the TRN-SR2–RanQ69LGTP structure (this work) and the Imp13 complex with
yeast Ran (Bono et al., 2010; PDB entry 2x19), as determined using PISA (Krissinel & Henrick, 2007). This includes van der Waals contacts, salt bridges and hydrogen bonds.
The secondary-structure elements for TRN-SR2 and Imp13 are indicated above and below the alignment, respectively.
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TRN-SR2 (Bono et al., 2010). The latter complex includes Ran from
the yeast Saccharomyces cerevisiae rather than human Ran (90%
sequence identity). In line with the considerable homology between
TRN-SR2 and Imp13, the overall HEAT-based structure of both
proteins is similar (Fig. 5). However, the Imp13 solenoid wraps
around the Ran globule in a somewhat less tight way than TRN-SR2,
so that HEATrepeats 7 and 8 of Imp13 make only a few contacts with
Ran, in contrast to our TRN-SR2 complex (Fig. 3). Moreover, there is
some conservation but also considerable differences in the specific
interactions (hydrogen bonding and salt bridges) that RanGTP
makes with either of the two proteins. In particular, superposition
of the two complexes reveals that as few as only four salt bridges
(involving three Ran residues Asp77, Arg110 and Arg166) and three
hydrogen bonds (involving Ran residues 47, 78 and 79) are structu-
rally preserved (Fig. 4). Of note, the Ran-binding domain of these two
importins (HEAT repeats 1–9) is somewhat more conserved (amino-
acid sequence identity 26.0%) than the rest of the molecule
(sequence identity of 20.1%).
As this paper was being written up, Maertens et al. (2014) reported
the crystal structures of human TRN-SR2 on its own and in two
complexes, including the RanQ69LGTP complex (PDB entry 4c0q).
Compared with our structure, the latter structure was determined in
a distinct space group P1 with two complexes per asymmetric unit at
3.42 A˚ resolution. Together with a better resolution, our structure
additionally reveals several surface loops (residues 110–194, 354–362,
625–633 and 672–676). The overall conformation of TRN-SR2 in the
two crystal structures is very similar, especially for the N-terminal
part, which shows an identical mode of RanGTP binding. For a
detailed comparison of the two structures, we have aligned them by
HEATrepeats 1–15. Such a superposition yields an r.m.s. deviation of
only 1.2 A˚ for all C atoms of HEATs 1–15. However, the C-terminal
parts of the TRN-SR2 molecule (repeats 16–20) in the two structures
gradually deviate more significantly. This appears to be owing to a
different packing in the two crystals and to intrinsic flexibility of the
TRN-SR2 solenoid. The largest differences in the C positions (up to
7 A˚) are within the last two HEATs (19 and 20).
Determination of the atomic structure of TRN-SR2 will provide a
basis for a fundamentally better understanding of its functioning at
the molecular level. As outlined in x1, besides its involvement in
other human diseases, TRN-SR2 plays a key role in HIV infection.
Indeed, the nuclear import of the HIV pre-integration complex can
be seen as the bottleneck for HIV replication, as it is an essential
prerequisite for the integration of the viral genome into the host cell,
which ultimately leads to persistent infection. We believe that
targeting the interaction between TRN-SR2 and HIV integrase may
be a promising avenue for new drug development, complementing
existing therapies.
We thank Stephen Weeks for helpful advice on cloning and protein
expression, Stephanie De Houwer for discussions and Maria-
Despoina Charavgi for valuable advice on crystallography. This work
was supported by the Research Foundation Flanders (FWO) grant
G0665.12 (to SVS and FC). Research at the Laboratory of Molecular
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Figure 4
Hydrogen bonds (***) and salt bridges (+++) formed between RanGTP and TRN-
SR2 (left) and Imp13 (right) in their respective complexes. The interfaces were
analyzed with PISA (Krissinel & Henrick, 2007). The interactions involving
structurally equivalent pairs of residues in the two complexes are shaded grey. Ran
residue 82 is Gln in human Ran (used for the TRN-SR2 complex) and Asn in yeast
Ran (used for the Imp13 complex). Ran residues involved in the interaction in both
complexes are shown in bold.
Figure 5
Comparison of the TRN-SR2–RanQ69LGTP complex and the Imp13 complex with
yeast Ran (PDB entry 2x19), with the HEATrepeats indicated as H1–H20. The two
complexes were superimposed by the Ran molecule (yellow semi-transparent
surface). Overall, TRN-SR2 (green) and Imp13 (violet) wrap around Ran in a very
similar manner, but some of the -helices (cylinders) are considerably shifted.
electronic reprint
Virology and Gene Therapy is also funded by the Belgian IAP
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